Public sponsors must follow ethical rules too

gan Kristiansen, Ivar Sønbø
Cyhoeddwyd 1999

Simple parametric survival analysis with anonymized register data: A cohort study with truncated and interval censored event and censoring times

gan Støvring, Henrik, Kristiansen, Ivar S
Cyhoeddwyd 2011

Diabetes: cost of illness in Norway

gan Jenssen Trond, Solli Oddvar, Kristiansen Ivar S
Cyhoeddwyd 2010-09-01

Diabetes: cost of illness in Norway

gan Solli, Oddvar, Jenssen, Trond, Kristiansen, Ivar S
Cyhoeddwyd 2010

Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave

gan Kristiansen Ivar, Xue Yiting, de Blasio Birgitte
Cyhoeddwyd 2010-11-01

Influenza pandemic: perception of risk and individual precautions in a general population. Cross sectional study

gan Kristiansen, Ivar S, Halvorsen, Peder A, Gyrd-Hansen, Dorte
Cyhoeddwyd 2007

Modeling the cost of influenza: the impact of missing costs of unreported complications and sick leave

gan Xue, Yiting, Kristiansen, Ivar Sønbø, de Blasio, Birgitte Freiesleben
Cyhoeddwyd 2010

Dynamic modelling of costs and health consequences of school closure during an influenza pandemic

gan Xue, Yiting, Kristiansen, Ivar Sønbø, de Blasio, Birgitte Freiesleben
Cyhoeddwyd 2012

Decisions on statin therapy by patients’ opinions about survival gains: cross sectional survey of general practitioners

gan Halvorsen, Peder A., Aasland, Olaf Gjerløw, Kristiansen, Ivar Sønbø
Cyhoeddwyd yn BMC Fam Pract (2015)

Effect of organised mammography screening on stage-specific incidence in Norway: population study

gan Lousdal, Mette L, Kristiansen, Ivar S, Møller, Bjørn, Støvring, Henrik
Cyhoeddwyd yn Br J Cancer (2016)

Cost-effectiveness analysis of five procedures for great saphenous vein reflux in a Norwegian healthcare setting or societal setting

gan Inderhaug, Eivind, Schelp, Carl-Henrik, Glambek, Inge, Kristiansen, Ivar S
Cyhoeddwyd yn SAGE Open Med (2018)

General population norms for the EQ-5D-3 L in Norway: comparison of postal and web surveys

gan Stavem, Knut, Augestad, Liv A, Kristiansen, Ivar S, Rand, Kim
Cyhoeddwyd yn Health Qual Life Outcomes (2018)

Norwegian Physicians' Knowledge of and Opinions about Evidence-Based Medicine: Cross-Sectional Study

gan Ulvenes, Lidziya Vanahel, Aasland, Olaf, Nylenna, Magne, Kristiansen, Ivar Sønbø
Cyhoeddwyd 2009

General practitioners' adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study

gan Dybdahl, Torben, Andersen, Morten, Kragstrup, Jakob, Kristiansen, Ivar Sønbø, Søndergaard, Jens
Cyhoeddwyd 2005

Primary care physicians’ adoption of new drugs is not associated with their clinical interests: A pharmacoepidemiologic study

gan Dybdahl, Torben, Søndergaard, Jens, Kragstrup, Jakob, Kristiansen, Ivar Sønbø, Andersen, Morten
Cyhoeddwyd 2011

The healthcare costs of treating human papillomavirus-related cancers in Norway

gan Hylin, Hannah, Thrane, Helene, Pedersen, Kine, Kristiansen, Ivar S., Burger, Emily A.
Cyhoeddwyd yn BMC Cancer (2019)

Phase- and gender-specific, lifetime, and future costs of cancer: A retrospective population-based registry study

gan Bugge, Christoffer, Brustugun, Odd Terje, Sæther, Erik Magnus, Kristiansen, Ivar Sønbø
Cyhoeddwyd yn Medicine (Baltimore) (2021)

Can postponement of an adverse outcome be used to present risk reductions to a lay audience? A population survey

gan Kristiansen Ivar, Gyrd-Hansen Dorte, Dahl Rasmus, Nexøe Jørgen, Bo Nielsen Jesper
Cyhoeddwyd 2007-03-01

Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?

gan Stovring, Henrik, Gyrd-Hansen, Dorte, Kristiansen, Ivar S, Nexoe, Jorgen, Nielsen, Jesper B
Cyhoeddwyd 2008

Laypersons' understanding of relative risk reductions: Randomised cross-sectional study

gan Sorensen, Lene, Gyrd-Hansen, Dorte, Kristiansen, Ivar S, Nexøe, Jørgen, Nielsen, Jesper B
Cyhoeddwyd 2008